Kiniksa Pharmaceuticals (KNSA) Cash flow

558 Followers

Kiniksa Pharmaceuticals Cash Flow

KNSA's free cash flow for Q4 2025 was $53.26M. For the 2025 fiscal year, KNSA's free cash flow was decreased by $0.00 and operating cash flow was $53.89M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ 25.69M	$ 25.69M	$ 13.30M	$ 5.81M	$ -126.30M
Investing Cash Flow	$ 37.67M	$ 37.67M	$ -29.56M	$ -8.08M	$ 128.63M
Financing Cash Flow	$ 12.27M	$ 12.27M	$ 1.50M	$ 2.52M	$ 5.88M
End Cash Position	$ 183.58M	$ 183.58M	$ 107.95M	$ 122.72M	$ 122.47M
Free Cash Flow	$ 25.41M	$ 25.41M	$ 13.17M	$ 5.70M	$ -146.71M

Currency in USD